Current Value
$1.611 Year Return
Current Value
$1.611 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | -13.85% | $12.57B | -95.57% | 2.41% |
NOC | -11.60% | $75.00B | +20.65% | 1.63% |
BAH | -10.57% | $13.37B | -31.47% | 1.97% |
TAP | -8.64% | $9.52B | -3.64% | 3.68% |
VRCA | -8.62% | $75.38M | -90.26% | 0.00% |
DECK | -8.29% | $14.70B | -34.38% | 0.00% |
CALM | -7.83% | $5.43B | +62.54% | 6.50% |
GSHD | -7.76% | $2.42B | +63.03% | 0.00% |
COR | -7.64% | $57.58B | +33.69% | 0.73% |
HUSA | -7.14% | $20.46M | -9.15% | 0.00% |
CODI | -6.69% | $471.73M | -72.86% | 15.72% |
HCA | -6.39% | $91.53B | +20.02% | 0.72% |
CNXC | -6.38% | $3.56B | -20.60% | 2.30% |
SRRK | -6.14% | $3.66B | +319.00% | 0.00% |
MKC | -5.91% | $19.31B | -1.09% | 2.45% |
WRB | -5.90% | $26.35B | +31.09% | 0.48% |
WIT | -5.68% | $30.16B | -13.77% | 2.36% |
OOMA | -5.45% | $334.79M | +21.30% | 0.00% |
BTCT | -5.30% | $29.39M | +101.55% | 0.00% |
SAR | -5.12% | - | - | 13.01% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EBS | 30.47% | $396.23M | -35.46% | 0.00% |
TYRA | 30.32% | $580.17M | -45.64% | 0.00% |
QXO | 29.18% | $14.11B | -60.25% | 0.00% |
CYRX | 28.99% | $376.03M | +0.94% | 0.00% |
DOUG | 28.64% | $219.18M | +94.49% | 0.00% |
QBTS | 27.26% | $4.95B | +1,090.23% | 0.00% |
RVMD | 26.96% | $7.15B | -16.59% | 0.00% |
DNTH | 26.78% | $644.16M | -30.93% | 0.00% |
IRBT | 26.68% | $150.24M | -54.78% | 0.00% |
CRBU | 26.66% | $158.11M | -20.19% | 0.00% |
ZNTL | 26.62% | $97.85M | -65.83% | 0.00% |
NTRA | 26.52% | $21.60B | +40.40% | 0.00% |
ABCL | 26.39% | $1.27B | +32.50% | 0.00% |
AVDL | 26.22% | $972.81M | -39.37% | 0.00% |
SPHR | 26.01% | $1.60B | +2.19% | 0.00% |
BSY | 26.00% | $17.29B | +15.25% | 0.46% |
YMAB | 25.88% | $197.49M | -66.41% | 0.00% |
CRSP | 25.74% | $4.87B | -1.81% | 0.00% |
XWDIX | 25.72% | - | - | 11.93% |
NVEC | 25.64% | $370.14M | -0.75% | 5.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.34% | $200.94M | 0.85% |
TAIL | -16.15% | $94.90M | 0.59% |
VIXM | -15.91% | $22.99M | 0.85% |
BTAL | -15.20% | $310.24M | 1.43% |
ULST | -12.56% | $592.71M | 0.2% |
IVOL | -10.48% | $341.06M | 1.02% |
USDU | -8.86% | $129.88M | 0.5% |
PSQA | -6.69% | $36.50M | 0.2% |
UUP | -5.49% | $183.22M | 0.77% |
BUXX | -5.04% | $312.54M | 0.25% |
TDTT | -4.35% | $2.63B | 0.18% |
STOT | -4.23% | $254.22M | 0.45% |
STPZ | -4.16% | $443.85M | 0.2% |
UTWO | -3.64% | $376.64M | 0.15% |
SPTS | -3.49% | $5.78B | 0.03% |
YEAR | -3.44% | $1.47B | 0.25% |
CLIP | -3.28% | $1.51B | 0.07% |
CTA | -2.44% | $1.07B | 0.76% |
SPIP | -2.35% | $951.55M | 0.12% |
VTIP | -2.20% | $15.19B | 0.03% |
Yahoo
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
Yahoo
By David Bautz, PhD NYSE:NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface structures to trap and dismantle viruses before they infect host cells. The company’s lead development candidate, NV-387, has shown promising preclinical activity against
Yahoo
SHELTON, CT / ACCESS Newswire / July 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
Yahoo
SHELTON, CT / ACCESS Newswire / June 18, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), asserts that with new rising variants of COVID and Bird Flu, the single broad-spectrum antiviral drug NV-387 is well-positioned ...
Yahoo
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
Yahoo
SHELTON, CT / ACCESS Newswire / May 28, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting ...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSV | -0.03% | $38.00B | 0.03% |
TYA | 0.06% | $149.83M | 0.15% |
BNDX | 0.08% | $67.48B | 0.07% |
DUSB | 0.09% | $1.36B | 0.15% |
IBTM | 0.09% | $317.86M | 0.07% |
GOVT | 0.10% | $27.40B | 0.05% |
SCHP | 0.14% | $13.04B | 0.03% |
AGZD | -0.15% | $98.57M | 0.23% |
ICSH | -0.21% | $5.96B | 0.08% |
VGIT | -0.21% | $31.83B | 0.04% |
UBND | 0.23% | $1.02B | 0.4% |
TIPZ | 0.24% | $94.25M | 0.2% |
IBTF | 0.32% | $1.98B | 0.07% |
FLGV | -0.35% | $1.02B | 0.09% |
BSCP | 0.37% | $3.25B | 0.1% |
SPTI | -0.39% | $8.68B | 0.03% |
IBTH | 0.42% | $1.62B | 0.07% |
SHY | -0.45% | $23.69B | 0.15% |
FXY | 0.48% | $798.58M | 0.4% |
UNG | 0.51% | $416.42M | 1.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRGS | 0.01% | $2.10B | -11.47% | 0.36% |
PGR | -0.01% | $145.01B | +13.94% | 1.99% |
EAT | 0.02% | $7.35B | +159.66% | 0.00% |
SMWB | 0.03% | $689.14M | +18.52% | 0.00% |
WNS | 0.05% | $3.20B | +28.86% | 0.00% |
MOH | -0.06% | $11.87B | -22.90% | 0.00% |
SITC | 0.07% | $599.45M | +10.08% | 0.00% |
WTW | -0.08% | $30.65B | +17.40% | 1.17% |
KNX | 0.11% | $7.58B | -6.89% | 1.46% |
CLB | 0.11% | $583.22M | -45.89% | 0.32% |
AWK | -0.12% | $27.95B | +5.15% | 2.18% |
LFVN | -0.13% | $155.84M | +97.76% | 1.32% |
IT | 0.13% | $28.73B | -17.96% | 0.00% |
JELD | -0.14% | $383.85M | -69.30% | 0.00% |
UFI | -0.16% | $88.68M | -16.00% | 0.00% |
AFG | -0.17% | $10.72B | +5.90% | 2.45% |
BRX | -0.17% | $7.94B | +8.58% | 4.38% |
WTI | 0.18% | $267.25M | -27.02% | 2.22% |
JNJ | -0.18% | $377.32B | +5.08% | 3.20% |
ERII | 0.19% | $715.03M | -11.11% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 31.50% | $45.27M | 0.5% |
ARKG | 29.32% | $1.10B | 0.75% |
ICVT | 27.61% | $2.71B | 0.2% |
PBW | 25.39% | $309.26M | 0.65% |
XBI | 25.39% | $5.19B | 0.35% |
CWB | 25.37% | $3.95B | 0.4% |
PBD | 24.90% | $77.17M | 0.75% |
ULTY | 24.66% | $1.22B | 1.3% |
QTUM | 24.26% | $1.71B | 0.4% |
PTH | 24.16% | $97.64M | 0.6% |
IWC | 24.07% | $846.53M | 0.6% |
GRID | 23.96% | $2.71B | 0.56% |
IPO | 23.67% | $144.50M | 0.6% |
ERTH | 23.66% | $139.12M | 0.67% |
BOTZ | 23.44% | $2.71B | 0.68% |
BUZZ | 23.42% | $77.70M | 0.76% |
EZA | 23.35% | $413.93M | 0.59% |
YMAX | 23.34% | $977.64M | 1.28% |
ARKK | 23.28% | $7.18B | 0.75% |
HEAL | 23.26% | $43.38M | 0.5% |